Table 3.
Variables | Liver abscess with predisposing factor | P (Univariate) | P (Multivariate) | OR | 95% CI for OR | |
---|---|---|---|---|---|---|
No | Yes | |||||
Older patienta | 7/53 | 5/72 | 0.366 | |||
Male gender, n (%) | 5/59 | 7/66 | 0.714 | |||
Comorbidities | ||||||
Diabetes mellitus, n (%) | 10/119 | 2/6 | 0.147 | |||
Chronic liver disease, n (%) | 9/118 | 3/7 | 0.059 | |||
Biliaryenteric anastomosis, n (%) | 11/121 | 1/4 | 0.372 | |||
ECOG score (1), n (%) | 10/113 | 2/12 | 0.353 | |||
Child-Pugh Class B, n (%) | 10/118 | 2/7 | 0.179 | |||
Leukopenia, n (%) | 12/115 | 0/10 | 0.600 | |||
Three or more tumors, n (%) | 5/35 | 7/90 | 0.462 | |||
Larger MTDb, n (%) | 1/65 | 11/60 | 0.004 | |||
PVTT, n (%) | 10/119 | 2/6 | 0.186 | |||
Antibiotic prophylaxis, n (%) | 11/118 | 1/7 | 0.529 | |||
SC within 3 m before DEB-TACE, n (%) | 6/122 | 6/3 | <0.001 | <0.001 | 5.49 | 0.34–13.54 |
Sub segmental embolization, n (%) | 4/22 | 8/103 | 0.241 | |||
Grade 1 artery occlusion, n (%) | 2/122 | 10/3 | <0.001 |
Older patient was defined as age above the median.
Larger MTD was defined as maximum tumor diameter above the median.